Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.

Pneumocystis PCR Positive: PJP or Airway Colonization?

Kategorier
Articles

Pneumocystis PCRLab InterpretationRespiratory Health A pneumocystis PCR positive result detects fungal DNA, not automatically pneumonia. Active PJP is more likely with immune suppression, compatible breathing symptoms, low oxygen and imaging changes; severe or rapidly worsening breathlessness needs emergency evaluation. Medically reviewed by Thomas Klein, MD Published 6 November 202616 min read 🧬Trusted by 2 million […]

Alport Syndrome Genetic Testing: Genes and Family Risk

Kategorier
Articles

Alport SyndromeGenetic ResultsFamily Risk Alport syndrome genetic testing can establish a molecular diagnosis when pathogenic or likely pathogenic COL4A3, COL4A4 or COL4A5 findings fit the inheritance pattern. A variant of uncertain significance does not confirm Alport syndrome; confirmed findings help determine kidney surveillance, hearing and eye assessments, and which relatives need testing. Medically reviewed by […]

Everolimus Trough Level: Safe Targets and Test Timing

Kategorier
Articles

EverolimusTransplant MonitoringLab Interpretation An everolimus trough level of 3–8 ng/mL is commonly targeted in certain transplant regimens, usually using a sample collected immediately before the next dose. Your transplant protocol, other medicines and collection timing determine what your result means; cancer treatment uses different dosing principles, and you should not change doses yourself. Medically reviewed […]

Lp-PLA2 Test Results: What Elevated Activity Means

Kategorier
Articles

Lp-PLA2Lab InterpretationCardiovascular Risk Elevated Lp-PLA2 can be associated with higher cardiovascular risk, but it cannot diagnose an artery blockage. The assay method, lipid profile and overall risk matter more than the flag alone. Medically reviewed by Thomas Klein, MD Published 6 November 202618 min read 📈Trusted across 127+ countries for fast, accurate AI-powered blood test […]

UGT1A1 Test Before Irinotecan: Side Effects and Dosing

Kategorier
Articles

UGT1A1PharmacogeneticsChemotherapy Safety UGT1A1 testing can identify reduced clearance of irinotecan’s active metabolite and support a safer starting dose. It cannot predict every reaction, and the decision depends on the exact formulation, regimen, and your oncology team’s assessment. Medically reviewed by Thomas Klein, MD Published 5 November 202617 min read 🩸Upload your blood test PDF and […]

Schistosoma Antibody Positive: When Treatment Is Needed

Kategorier
Articles

SchistosomiasisLab Interpretation A positive Schistosoma antibody result may justify treatment after credible freshwater exposure if you have never received adequate therapy, but it cannot prove active infection or confirm cure. Your exposure dates, previous treatment and additional tests determine the next step. Medically reviewed by Thomas Klein, MD Published 5 November 202617 min read 🧪Kantesti […]

Hereditary ATTR Amyloidosis: What Your TTR Variant Means

Kategorier
Articles

TTR GeneticsAmyloidosisLab Interpretation A disease-causing TTR variant establishes inherited susceptibility to hereditary ATTR amyloidosis—not proof of active disease. An uncertain variant does not establish that susceptibility; symptoms require a separate specialist assessment, and wild-type ATTR develops without a disease-causing inherited TTR variant. Medically reviewed by Thomas Klein, MD Published 5 November 202616 min read 🔬Kantesti […]

Influenza A Positive: Treatment and Recovery Timeline

Kategorier
Articles

Influenza ATest InterpretationRespiratory Health A positive flu A test usually means influenza virus was detected in your respiratory sample. Most uncomplicated symptoms improve within 3–7 days; antiviral decisions depend on symptom timing, risk factors, and illness severity. Medically reviewed by Thomas Klein, MD Published 5 November 202619 min read ⚕️Join 2M+ users worldwide interpreting their […]

High Chromogranin A: Tumor Risk, PPI Effects and Retests

Kategorier
Articles

Chromogranin ALab InterpretationNeuroendocrine Health High chromogranin A alone does not mean you have a neuroendocrine tumor. Acid-suppressing medicines, reduced kidney function, and the laboratory method can change the result—and the safest next step depends on why the test was ordered. Medically reviewed by Thomas Klein, MD Published 5 November 202617 min read 📊Upload your lab […]

Topiramate Level: Useful Monitoring, Ranges and Limits

Kategorier
Articles

TopiramateMedication MonitoringLab Interpretation Topiramate concentrations are not routinely checked because treatment response and side effects do not map reliably to one target number. Testing can clarify medication exposure or altered clearance; bicarbonate and kidney-function tests answer separate safety questions. Medically reviewed by Thomas Klein, MD Published 4 November 202617 min read 🩺Get a complete AI […]